Sean A. McCarthy, CEO at CytomX Therapeutics, Inc. (CTMX), sold 203,586 shares at $4.54 ($924K) on 2025-11-06, disclosed to the SEC on 2025-11-10.
Scheduled sale ($924k) by CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.54 | 101,793 | $462K | 50.0% |
| 2 | $4.54 | 101,793 | $462K | 50.0% |
| Total | $4.54 avg | 203,586 | $924K | 100% |
| Filing → |
| CTMX | SELL | 2025-06-17 | $299K | — | Filing → |
| CTMX | SELL | 2025-03-20 | $23K | — | Filing → |
| CTMX | SELL | 2024-08-22 | $17K | — | Filing → |